Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Translational Andrology and Urology|May 19, 2020
Clinical and genetic features of pediatric PCCs/PGLs patients: a single-center experience in ChinaMinghao Li, Cikui Wang, Peihua Liu, et al.European Journal of Endocrinology|December 9, 2025
Clinical and biochemical characteristics of patients with somatic HRAS-mutant pheochromocytoma and paragangliomaKun Wang, Zhi Li, Jing Zhang, et al.Iscience|October 20, 2023
The transcription factor IRF4 determines the anti-tumor immunity of CD8<sup>+</sup> T cellsHui Yan, Yulin Dai, Xiaolong Zhang, et al.Journal of Cancer|October 13, 2018
Adrenal incidentaloma: machine learning-based quantitative texture analysis of unenhanced CT can effectively differentiate sPHEO from lipid-poor adrenal adenomaXiaoping Yi, Xiao Guan, Chen Chen, et al.Frontiers in Immunology|November 15, 2021
<i>PMEPA1</i> Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder CancerDongxu Qiu, Jian Hu, Jiao Hu, et al.Journal of Endocrinological Investigation|August 20, 2025
Clinical and genetic features of older patients with pheochromocytomas and paragangliomas: A multicenter retrospective studyXiaowen Xu, Yingjie Shen, Jingjing Jiang, et al.Cellular and Molecular Life Sciences : CMLS|July 8, 2024
Nuclear translocation of ISG15 regulated by PPP2R2B inhibits cisplatin resistance of bladder cancerGaowei Huang, Jinwen Liu, Anze Yu, et al.Theranostics|February 4, 2021
Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancerJiao Hu, Anze Yu, Belaydi Othmane, et al.Trends in Biotechnology|August 7, 2024
Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistanceTianying Yuan, Xihong Fu, Rongcheng Hu, et al.Frontiers in Immunology|September 16, 2021
N<sup>6</sup>-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic TargetChao Quan, Othmane Belaydi, Jiao Hu, et al.Pageof 4